Form 8-K - Current report:
SEC Accession No. 0001104659-23-043318
Filing Date
2023-04-10
Accepted
2023-04-10 07:48:39
Documents
14
Period of Report
2023-04-10
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2312175d1_8k.htm   iXBRL 8-K 24028
2 EXHIBIT 99.1 tm2312175d1_ex99-1.htm EX-99.1 11327
6 GRAPHIC tm2312175d1_ex99-1img01.jpg GRAPHIC 2477
  Complete submission text file 0001104659-23-043318.txt   220039

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA pmn-20230410.xsd EX-101.SCH 3063
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE pmn-20230410_lab.xml EX-101.LAB 34476
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE pmn-20230410_pre.xml EX-101.PRE 22616
8 EXTRACTED XBRL INSTANCE DOCUMENT tm2312175d1_8k_htm.xml XML 3712
Mailing Address SUITE 200, 1920 YONGE STREET TORONTO A6 M4S 3E2
Business Address SUITE 200, 1920 YONGE STREET TORONTO A6 M4S 3E2 416-847-6898
ProMIS Neurosciences Inc. (Filer) CIK: 0001374339 (see all company filings)

EIN.: 000000000 | State of Incorp.: Z4 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41429 | Film No.: 23809722
SIC: 2834 Pharmaceutical Preparations